The world may be running after low-cost generic drugs to reduce health care expenditure, but in India, generic drug manufacturing companies (better known as pharmacies to the world) are struggling to gain respect. Recently, when a pharma industry official met Economic Affairs Secretary Arvind Mayaram and tried to push some industry demands for the upcoming Budget, the bureaucrat apparently told him Indian pharma companies did not need incentives because they never did any research and were mere copycats. The industry official says he wanted to ask Mayaram, Mr Bureaucrat, how much do you understand pharmaceuticals and chemistry?